Target therapeutic exploitation of engineered exosome-mediated delivery of ncRNAs in cancer.
- DOI
- 10.1038/s41417-026-01059-y
- Published
- 2026 Jun
- Container
- Cancer gene therapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41417-026-01059-y,
title = {Target therapeutic exploitation of engineered exosome-mediated delivery of ncRNAs in cancer.},
author = {Chaharlang F and Mahdipour N and Alizadeh Rami S and Angouti P and Ahmadi A and Khalaj-Kondori M},
year = {2026},
journal = {Cancer gene therapy},
doi = {10.1038/s41417-026-01059-y},
url = {https://doi.org/10.1038/s41417-026-01059-y}
}RIS
TY - JOUR TI - Target therapeutic exploitation of engineered exosome-mediated delivery of ncRNAs in cancer. AU - Chaharlang F AU - Mahdipour N AU - Alizadeh Rami S AU - Angouti P AU - Ahmadi A AU - Khalaj-Kondori M PY - 2026 JO - Cancer gene therapy DO - 10.1038/s41417-026-01059-y UR - https://doi.org/10.1038/s41417-026-01059-y ER -
APA
F, C., N, M., S, A. R., P, A., A, A., & M, K. (2026). Target therapeutic exploitation of engineered exosome-mediated delivery of ncRNAs in cancer.. Cancer gene therapy. https://doi.org/10.1038/s41417-026-01059-y
Source records
- pubmed · retrieved 2026-09-26T19:48:58.308Z